U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819306) titled 'The Effect of Hedia Diabetes Assistant on TiMe-in-range in People with Type 1 Diabetes and Sub-Optimal Glycemic Control in France - a Randomised Controlled Trial.' on Feb. 05.
Brief Summary: The goal of this randomized controlled study is to assess the clinical performance and safety of Hedia Diabetes Assistant in adults with type 1 diabetes and suboptimal glycemic control in France. The main question to answer is:
- Does Hedia Diabetes Assistant improve glycemic control? Researchers will compare Hedia Diabetes Assistant in addition to standard treatment to standard treatment alone to see if Hedia Diabetes Assistant can improve gly...